Vaccinations (Measles) (% of children ages 12-23 months): Q5 in Peru
Peru: Vaccinations (Measles) (% of children ages 12-23 months): Q5 was 79.0% in 2012. ▼ Falling
Vaccinations (Measles) (% of children ages 12-23 months): Q5 in Peru, 1992–2012
Source: Household Surveys (DHS, MICS). Measured in highest.
Analysis
In 2012, vaccinations (measles) (% of children ages 12-23 months): q5 in Peru stood at 79.0%.
Compared with earlier readings it is up 4.4% on the previous year and up 4.9% over ten years.
Over the whole period, vaccinations (measles) (% of children ages 12-23 months): q5 in Peru peaked at 91.8% in 1996 and was at its lowest, 73.3%, in 2008.
That places Peru 36th out of 42 countries with data for 2012, putting it in the bottom quarter.
Vaccinations (Measles) (% of children ages 12-23 months): Q5 in Peru, year by year
| Year | highest | Change |
|---|---|---|
| 1992 | 87.5% | — |
| 1996 | 91.8% | +4.9% |
| 2000 | 75.3% | -18.0% |
| 2006 | 78.1% | +3.7% |
| 2008 | 73.3% | -6.1% |
| 2009 | 73.3% | +0.0% |
| 2010 | 77.0% | +5.0% |
| 2011 | 75.7% | -1.7% |
| 2012 | 79.0% | +4.4% |
Peru compared with similar countries
- Peru's 79.0% is below the median for upper middle income countries, which is 85.2%, 93% of the median. (10 countries reporting)
- Peru's 79.0% is below the median for Latin America & Caribbean, which is 79.2%, 100% of the median. (5 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 89.7% | 87.5% | 91.8% | 2 |
| 2000s | 75.0% | 73.3% | 78.1% | 4 |
| 2010s | 77.2% | 75.7% | 79.0% | 3 |
Countries ranked near Peru
More health data for Peru
- Un projection of annual infant deaths, annual growth rate -1.88 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5045 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,235 deaths per 1,000 people (2090)
- Number of infants who die before age 1 782 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 2 (2025)
- Population ages 00-04, female, annual growth rate -0.3081 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.038 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.302 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is vaccinations (measles) (% of children ages 12-23 months): q5 in Peru?
- Vaccinations (measles) (% of children ages 12-23 months): q5 in Peru was 79.0% in 2012, according to Household Surveys (DHS, MICS).
- What is the highest vaccinations (measles) (% of children ages 12-23 months): q5 recorded in Peru?
- The highest recorded value was 91.8% in 1996.
- What is the lowest vaccinations (measles) (% of children ages 12-23 months): q5 recorded in Peru?
- The lowest recorded value was 73.3% in 2008.
- How does Peru rank for vaccinations (measles) (% of children ages 12-23 months): q5?
- Peru ranks 36th out of 42 countries with data for 2012.
- Is vaccinations (measles) (% of children ages 12-23 months): q5 rising or falling in Peru?
- Over the last ten years it is up 4.9%. The long-run trend across the full record is falling.
- Where does this Peru data come from?
- The figures come from Household Surveys (DHS, MICS), published as part of Vaccinations (Measles) (% of children ages 12-23 months): Q5 (highest). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 9 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Vaccinations: Percentage of children 12-23 months who have received specific vaccines by the time of the survey (according to the vaccination card or the mother's report). Children with all vaccinations refer children who have received BCG, measles, and three doses each of DPT and polio vaccine (excluding polio 0). Some MICS surveys refer children in different age groups (e.g. 18-29 months, or 15-26 months).